Cargando…

COVID-19 vaccines in 2023

Most Australian adults now have hybrid immunity to the SARS-CoV-2 virus, referring to a combination of protection from previous vaccine doses and past infection. Protection from both vaccination and past infection wanes over time. Booster doses are recommended to ensure that those who are at increas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharma, Ketaki, Li-Kim-Moy, Jean
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Therapeutic Guidelines 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665092/ http://dx.doi.org/10.18773/austprescr.2023.020

Ejemplares similares

Effectiveness of bivalent COVID-19 boosters against COVID-19 mortality in people aged 65 years and older, Australia, November 2022 to May 2023
por: Liu, Bette, et al.
Publicado: (2023)

Update on the status of COVID-19 vaccination in Italy—April 2023
por: Mattiuzzi, Camilla, et al.
Publicado: (2023)

Alignment of national COVID-19 vaccine recommendations for pregnant and lactating women
por: Giles, Michelle L, et al.
Publicado: (2021)

Vaccines for COVID-19: Where do we stand in 2021?
por: Sharma, Ketaki, et al.
Publicado: (2021)

Insights for COVID-19 in 2023
por: Sánchez, Francisco Javier Martín, et al.
Publicado: (2022)

Meningococcal vaccines in Australia: a 2019 update
por: Sharma, Ketaki, et al.
Publicado: (2019)

Testing for COVID-19: a 2023 update
por: Meumann, Ella M, et al.
Publicado: (2023)

Follow-up of COVID-19 Vaccine–related Axillary Lymphadenopathy before 12 Weeks Is Unnecessary
por: Moy, Linda, et al.
Publicado: (2022)

Correction: Mahasing et al. Myocarditis and Pericarditis following COVID-19 Vaccination in Thailand. Vaccines 2023, 11, 749
por: Mahasing, Chayanit, et al.
Publicado: (2023)

Reassessing the risks and benefits of COVID-19 precautions in 2023
por: Ollila, Thomas A., et al.
Publicado: (2023)

Use of Updated COVID-19 Vaccines 2023–2024 Formula for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2023
por: Regan, Joanna J., et al.
Publicado: (2023)

Assessing the robustness of COVID-19 vaccine efficacy trials: systematic review and meta-analysis, January 2023
por: Hoang, Thi Ngoc Anh, et al.
Publicado: (2023)

Human vaccines & immunotherapeutics: News January 2023
por: Ellis, Ronald, et al.
Publicado: (2023)

Human vaccines & immunotherapeutics: News March 2023
por: Ellis, Ronald, et al.
Publicado: (2023)

Human vaccines & immunotherapeutics: News February 2023
por: Ellis, Ronald, et al.
Publicado: (2023)

Human vaccines & immunotherapeutics: News May 2023
por: Ellis, Ronald, et al.
Publicado: (2023)

Human Vaccines & Immunotherapeutics: News April 2023
por: Ellis, Ronald, et al.
Publicado: (2023)

Human vaccines and immunotherapeutics: News September 2023
por: Ellis, Ronald, et al.
Publicado: (2023)

Human vaccines & immunotherapeutics: News August 2023
por: Ellis, Ronald, et al.
Publicado: (2023)

Human vaccines & immunotherapeutics: News July 2023
por: Ellis, Ronald, et al.
Publicado: (2023)

Human vaccines & immunotherapeutics: News June 2023
por: Ellis, Ronald, et al.
Publicado: (2023)

Human vaccines & immunotherapeutics: News October 2023
por: Ellis, Ronald, et al.
Publicado: (2023)

Comparative Effectiveness of COVID-19 Bivalent Versus Monovalent mRNA Vaccines in the Early Stage of Bivalent Vaccination in Korea: October 2022 to January 2023
por: Kim, Ryu Kyung, et al.
Publicado: (2023)

Influenza, Tdap, and COVID-19 Vaccination Coverage and Hesitancy Among Pregnant Women — United States, April 2023
por: Razzaghi, Hilda, et al.
Publicado: (2023)

COVID-19 vaccination acceptance and adherence among pregnant and lactating high-risk group individuals of Maharashtra State, India
por: Kumar, Vaibhav, et al.
Publicado: (2023)

The 2023 Impact of Inflammatory Bowel Disease in Canada: COVID-19 and IBD
por: Kaplan, Gilaad G, et al.
Publicado: (2023)

European Society of Breast Imaging (EUSOBI) guidelines on the management of axillary lymphadenopathy after COVID-19 vaccination: 2023 revision
por: Schiaffino, Simone, et al.
Publicado: (2023)

461. COVID-19 Hospitalizations among Vaccinated and Unvaccinated Immunocompromised Children, 23 States, December 2022 – April 2023
por: Campbell, Angela P, et al.
Publicado: (2023)

2365. Effectiveness of COVID-19 Vaccines Against Medically Attended COVID-19 in Pregnant Persons Within the VISION Network, December 2021 - April 2023
por: Ciesla, Allison Avrich, et al.
Publicado: (2023)

Estimate of COVID-19 Deaths, China, December 2022–February 2023
por: Du, Zhanwei, et al.
Publicado: (2023)

The manufacturing process should remain the focus for severe febrile reactions in children administered an Australian inactivated influenza vaccine during 2010
por: Li‐Kim‐Moy, Jean, et al.
Publicado: (2015)

Emil Gotschlich: Physician–scientist and vaccine pioneer (1935–2023)
por: Rappuoli, Rino
Publicado: (2023)

Editor’s Pick in May 2023
por: Kim, Chae-Yong, et al.
Publicado: (2023)

NPM 1 Mutations in AML—The Landscape in 2023
por: Sharma, Naman, et al.
Publicado: (2023)

JGP in 2023
por: Eisner, David A.
Publicado: (2023)

ESPR 2023
Publicado: (2023)

SPR 2023
Publicado: (2023)

APPSPGHAN 2023
Publicado: (2023)

MOCAST 2023
Publicado: (2023)

Ensembl 2023
por: Martin, Fergal J, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1s8b29n4d0cb3cmpgl9fb5ebpc